Advisor Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Advisor Group’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,775	Closed	-$72K	–	5569
2019 Q1	$72K	Buy	3,775 +3,665	+3,332%	+$59.5K	﹤0.01%	3123
2018 Q4	$1K	Hold	110	–	–	﹤0.01%	5073
2018 Q3	$1K	Buy	+110	New	+$1.1K	﹤0.01%	5074
2016 Q4	–	Sell	-100	Closed	–	–	4841
2016 Q3	$0	Hold	100	–	–	﹤0.01%	4842
2016 Q2	$0	Buy	+100	New	+$538	﹤0.01%	4661

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Advisor Group's OSIR Position: Q2 2019 in Review

Advisor Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 3,775 shares — an estimated $72K sold.

Advisor Group first reported a position in OSIR in Q2 2016 and held it in 5 quarters. The position peaked at $72K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Advisor Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Advisor Group sold 3,775 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $72K.
Advisor Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2016 and held it in 5 quarters.
Advisor Group's Osiris Therapeutics, Inc. Common Stock position peaked at $72K in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Advisor Group's 13F filing for Q2 2019, filed 31 Jul 2019.